The drug, which was intended to become a tool in the fight against hypertension, is recognized as hazardous to health due to multiple exceeded the content in its composition N-nitrosodiethylamine (NDEA).
After the publication of a detailed report of the expert group of the International Agency for research on cancer, from pharmacies USA confiscated all stocks of Irbesartan. The firm that manufactures this drug, Prinston Pharmaceutical, return to their stores sold all 8 parties to conduct examinations to determine the presence of drug carcinogenic compounds able to precipitate in the human body of malignant tumors. Simultaneously, experts recommend that patients who have been prescribed this medicine to ask physicians to replace Irbesartan secure counterparts.
The commotion caused by the dangerous ingredients in the N-nitrosodiethylamine - not the first similar case in the us market. Previously for similar reasons, had imposed a ban on the sales of Valsartan, Losartan, and Hydrochlorothiazide Amlopidine also made Chinese products.